Kim, Bong-Joon https://orcid.org/0000-0002-5435-7449
Cho, Kyoung-Im https://orcid.org/0000-0003-3137-0218
Kwon, Hyuck Moon https://orcid.org/0000-0001-9901-5015
Choi, Seung-Min https://orcid.org/0000-0003-3997-186X
Yoon, Chang-Hwan https://orcid.org/0000-0001-6305-4442
Lim, Sang Wook https://orcid.org/0000-0001-6916-4087
Joo, Seung-Jae https://orcid.org/0000-0002-4322-0703
Lee, Nam Ho https://orcid.org/0000-0001-8319-0185
Lim, Sang-Yup https://orcid.org/0000-0002-3042-6702
Lim, Seong-Hoon https://orcid.org/0000-0002-2941-2784
Kim, Hyo-Soo https://orcid.org/0000-0003-0847-5329
Funding for this research was provided by:
Chong Kun Dang Pharmaceutical Co., Ltd.
Article History
Received: 11 May 2021
Accepted: 7 November 2021
First Online: 1 March 2022
Declarations
:
: The study protocol was approved by the Institutional Review Board at each institution.
: Not applicable.
: All authors declare that they have no conflicts of interest regarding the content of this article.